ECS Botanics Holdings Ltd banner

ECS Botanics Holdings Ltd
ASX:ECS

Watchlist Manager
ECS Botanics Holdings Ltd Logo
ECS Botanics Holdings Ltd
ASX:ECS
Watchlist
Price: 0.005 AUD
Market Cap: AU$8m

ECS Botanics Holdings Ltd
Investor Relations

ECS Botanics Holdings Ltd. manufactures, supplies and retails cannabis products. The company is headquartered in Perth, Western Australia. The firm operates in two segments: ECS Botanics Pty Ltd is engaged in the sale of food and wellness products, and Murray Meds Pty Ltd and Flowerday Farms Pty Ltd are engaged in the sale of medicinal cannabis plant-related products. The firm offers Extra Virgin Tasmanian Hemp Seed Oil, Australian Hemp Seed Oil Capsules, Australian Hemp Seed Oil Capsules with Turmeric, Australian Hemp Hearts (Dehulled Seeds), Australian Hemp Protein, Natural Calm Terpene Blend, Natural Relief Terpene Blend, Natural Sleep Terpene Blend, Mexican Spiced Bean Soup and Indian Masala Lentil Soup. The firm owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing and manufacturing of medicinal cannabis.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Mar 4, 2026
AI Summary
Q2 2026

Revenue: Revenue grew 16.5% year‑on‑year, driven by a shift to B2C (now >60% of sales).

Profitability: Company returned to profitability with two consecutive quarters of positive operating cash flow.

Cost control: Cultivation and post‑harvest costs have fallen after investments in new PCEs and process improvements; wages and salaries reduced ~5% in H1.

Inventory accounting: Management flagged volatility from biological‑asset accounting and took a $880,000 non‑cash deferred tax impairment to conservatively manage the balance sheet.

CapEx: Major capital works are complete (no further large expansions planned); recent investments include 9 new PCEs and a 460 cubic‑meter curing room.

Commercial strategy: Focus is on branded B2C (OzSun, AVANI, AVA, Terphogz relaunch) for higher margins and brand loyalty; continuing B2B relationships with large customers and European distribution deals (Nimbus).

Regulatory & exports: Trial export batch to Germany imminent; export/import permits are in process and timing may be affected by logistics and geopolitical events.

Key Financials
Revenue growth
up 16.5% YoY
Operating cash flow
Two consecutive quarters positive
Deferred tax impairment
$880,000 non‑cash impairment
New production houses (PCEs)
9 constructed in the last round
Curing room capacity
460 cubic meters
Salaries and wages change
down 5% in H1
Capital raise
$1.9 million raised
Other Earnings Calls
2026

Management

Ms. Nan-Maree Schoerie Dip Chem
MD & Executive Director
No Bio Available
Mr. Arthur Sun
Chief Financial Officer
No Bio Available
Mr. Nicholas Thomas
Chief Operating Officer
No Bio Available
Mr. Michael Clark
Head of European Operations
No Bio Available
Mr. Mauro Piccini
Company Secretary
No Bio Available

Contacts

Address
WESTERN AUSTRALIA
Perth
Se 2 L 1, 1 Altona St
Contacts
+61865591792.0
www.axxis.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett